# PINGUIN (Postpartum Intervention in Women With Gestational Diabetes Using Insulin)

> **NCT01018602** · PHASE2 · UNKNOWN · sponsor: **Institut fur Diabetesforschung, Munich, Germany** · enrollment: 140 (estimated)

## Conditions studied

- Insulin-dependent Gestational Diabetes

## Interventions

- **DRUG:** vildagliptin
- **DRUG:** inactive pill

## Key facts

- **NCT ID:** NCT01018602
- **Lead sponsor:** Institut fur Diabetesforschung, Munich, Germany
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-01
- **Primary completion:** 2012-06
- **Final completion:** 2015-06
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2011-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01018602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01018602, "PINGUIN (Postpartum Intervention in Women With Gestational Diabetes Using Insulin)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01018602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*